Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-12-023967
Filing Date
2012-05-09
Accepted
2012-05-09 16:04:04
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS, INC. 10-Q 03-31-2012 form10q.htm 10-Q 1377927
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 15899
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 15619
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 9651
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 9919
  Complete submission text file 0001140361-12-023967.txt   5683132

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rnn-20120331.xml EX-101.INS 1067267
7 XBRL SCHEMA DOCUMENT rnn-20120331.xsd EX-101.SCH 17885
8 XBRL CALCULATION LINKBASE DOCUMENT rnn-20120331_cal.xml EX-101.CAL 38759
9 XBRL LABEL LINKBASE DOCUMENT rnn-20120331_lab.xml EX-101.LAB 143526
10 XBRL PRESENTATION LINKBASE DOCUMENT rnn-20120331_pre.xml EX-101.PRE 90807
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34079 | Film No.: 12825709
SIC: 2834 Pharmaceutical Preparations